Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0K1PR
|
|||
| Former ID |
DIB016598
|
|||
| Drug Name |
B-428
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Terminated | [1] | |
| Company |
Eisai Co Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H7IN2S
|
|||
| Canonical SMILES |
C1=CC2=C(C=C(S2)C(=N)N)C(=C1)I
|
|||
| InChI |
1S/C9H7IN2S/c10-6-2-1-3-7-5(6)4-8(13-7)9(11)12/h1-4H,(H3,11,12)
|
|||
| InChIKey |
YERQOXAYAFWFEJ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 154628-42-9
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009078) | |||
| REF 2 | Natural and synthetic inhibitors of the tumor-associated serine protease urokinase-type plasminogen activator. Adv Exp Med Biol. 2000;477:331-41. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.